Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market [2010-2019]
by Sarah Davis Digital MarketerDec., 18, 2015, Mumbai, India: Market Reports on China presents the report, on “Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market [2010-2019]”. Piperacillin sodium and tazobactam sodium has been widely applied in the clinic with efficacy being confirmed by the randomized controlled trials conducted by multiple centers at home and abroad.
Piperacillin
sodium and tazobactam sodium is the compound drug of piperacillin
sodium and tazobactam sodium, the former being semi-synthesized
broad-spectrum penicillin while the latter being β-lactamase
inhibitor. Tazobactam sodium can prevent piperacillin from the β-lactamase
hydrolysis of some drug-resistant bacteria so as to maintain
piperacillins antimicrobial activity or even expand its spectrum. The
injection product of Piperacillin sodium and tazobactam sodium
(piperacillin sodium and tazobactam sodium for injection) is often
used in the clinic.
Since its first marketing in France in
1992, piperacillin sodium and tazobactam sodium has entered the US,
mainland Europe, Japan and Singapore. According to market survey,
piperacillin sodium and tazobactam sodium develops fast after
entering China in Oct. 1998, annual sales value rising from less than
CNY 2 million in 2005 to CNY 1.064 billion in 2014 and CAGR during
this period reaching 22.2%.
Wyeth Pharmaceutical Co., Ltd
(US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group
Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United
Laboratories occupy the majority of the Chinese market, among which
Wyeth Pharmaceutical Co., Ltd (US) has the largest market share of
about 36% for sales value in 2014.
Piperacillin sodium and
tazobactam sodium has been widely applied in the clinic with efficacy
being confirmed by the randomized controlled trials conducted by
multiple centers at home and abroad. And it has been recommended by
many domestic and foreign treatment guidelines as the first choice of
the initial empirical therapy for hospital infection caused by
unidentified pathogenic bacteria. The market size of piperacillin
sodium and tazobactam sodium is expected to grow in China or in the
whole world.
Readers can get at least the following
information from this report:
- market size of piperacillin sodium
and tazobactam sodium in China
- competitive landscape of
piperacillin sodium and tazobactam sodium in Chinese market
-
price of piperacillin sodium and tazobactam sodium made by different
enterprises in China
- market outlook of piperacillin sodium and
tazobactam sodium in China
The author suggests the following
groups of people purchase this report:
- manufacturers of
anti-infectious drugs
- investors/ research institutions
interested in Chinese medicine market
- any interest in the
Chinese medicine market, please contact for customized survey service
Table
of Contents
1
Related Concepts of Piperacillin Sodium Tazobactam Sodium
1.1
Indication
1.2 Sales Status in Global Market
2
Market Profile of Piperacillin Sodium and Tazobactam Sodium in China
2.1
Patent and Approval Status of Piperacillin Sodium and Tazobactam
Sodium in China
2.2 Major Manufacturers
2.3 Market Size
3
Survey on Sales Status of Piperacillin Sodium and Tazobactam Sodium
in China, 2010-2014
3.1
Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by
Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2
Sales Volume by Regions
Related Reports:http://www.marketreportsonchina.com/market-research-report/life-sciences.html
About Author Bio: Sarah Davis is working with MarketReportsonChina which is a portal where you can access thousands of reports on China starting from Aeronautics to Zinc (A-Z). The website provides market reports on different sectors.
Contact
Us
Market Reports on China
Contact No: India:
+91.22.27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com/about.php
Twitter:
https://twitter.com/ReportsonChina
Sponsor Ads
Created on Dec 31st 1969 18:00. Viewed 0 times.